Oppenheimer Adjusts Agilysys AGYS Price Target Upward by 10 Japan Core Inflation Slips to Over FourYear Low Dampening Expectations for BOJ Rate Hike REPLOID Group AG Faces Auditor Appointment Issues 2025 Annual Report Delayed Health Ministry Reclassifies CNS Drug Pregabalin to Schedule H1 to Curb Misuse Treasury Yield Surge Challenges RiskFree Status Pushing Investors Toward HigherYielding Bonds SGX RegCo Gives Suspended Firms Three Years to Resume Trading or Face Delisting AkzoNobel Rejects 125 Billion Joint Takeover Bid from Nippon Paint and SherwinWilliams CSGP Q1 2026 Earnings EPS Surpasses Estimates by 225 but Shares Slide 42